Sleep Disorders

>

Latest News

Eli Lilly Expands Zepbound Access with New Vial Doses, Self-Pay Savings / Image credit: ©Douglas/AdobeStock
Eli Lilly Expands Zepbound Access with New Vial Doses, Self-Pay Savings

February 26th 2025

Eli Lilly launched 2 new strengths of Zepbound single-dose vials for self-pay patients, and lowered the price of 2.5 mg and 5 mg vials.

Obstructive Sleep Apnea and Hypertension Update: FDA Clears Phase 2 Trial of Lorundrostat, an Oral Aldosterone Synthase Inhibitor
Obstructive Sleep Apnea and Hypertension Update: FDA Clears Phase 2 Trial of Lorundrostat, an Oral Aldosterone Synthase Inhibitor

January 17th 2025

FDA Approves Tirzepatide as First Drug for Obstructive Sleep Apnea with Obesity
FDA Approves Tirzepatide as First Drug for Obstructive Sleep Apnea with Obesity

December 20th 2024

Role of Sleep in Dementia and Associated Comorbidities: Daily Dose / image credit: ©New Africa/AdobeStock
Role of Sleep in Dementia and Associated Comorbidities: Daily Dose

December 13th 2024

New Review Highlights Need to Address Sleep Disturbances in Patients with Dementia / Image credit: ©netrun78/AdobeStock
New Review Highlights Need to Address Sleep Disturbances in Patients with Dementia

December 2nd 2024

More News

© 2025 MJH Life Sciences

All rights reserved.